Altshuler David, Chief Officer of Vertex Pharmaceuticals VRTX, has filed 0 purchases and 38 sales on the open market. The latest trade was on 01/22.

AD

AD

Altshuler David

EVP, Chief Scientific Officer

Company

Vertex Pharmaceuticals VRTX

First filing

23/02/03

Trades

63 trades

Buys / sales

0 / 38

12-month net buying

No record

Last trade

01/22

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/05/15	25/05/19	52 sh	$424.69	$22,083.88	−0.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/03/13	25/03/17	3,231 sh	$510.00	$1,647,810	−12.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/03/10	25/03/12	3,231 sh	$500.00	$1,615,500	−10.9%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/03/03	25/03/05	3,231 sh	$490.00	$1,583,190	−9.8%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/02/27	25/02/28	1,272 sh	$480.00	$610,560	−3.7%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/02/25	25/02/26	848 sh	$480.95	$407,845.6	−2.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/02/20	25/02/24	1,111 sh	$480.00	$533,280	−2.4%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/11/15	24/11/19	15 sh	$478.56	$7,178.4	−0.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/05/15	24/05/17	54 sh	$430.93	$23,270.22	−0.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/26	24/02/27	4,239 sh	$425.70	$1,804,542.3	−14.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/21	24/02/23	3,002 sh	$421.77	$1,266,153.54	−8.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/20	24/02/21	4,002 sh	$420.79	$1,684,001.58	−9.8%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/12	24/02/13	3,145 sh	$420.24	$1,321,654.8	−6.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/11/15	23/11/17	19 sh	$369.92	$7,028.48	−0.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/08/09	23/08/11	63 sh	$345.51	$21,767.13	−0.2%
Vertex PharmaceuticalsVRTX	Open-market sale	23/02/27	23/02/28	4,238 sh3 trades	$287.51avg.	$1,218,449.48	−11.7%
Vertex PharmaceuticalsVRTX	Open-market sale	23/02/21	23/02/22	4,002 sh4 trades	$293.77avg.	$1,175,676.13	−9.0%
Vertex PharmaceuticalsVRTX	Open-market sale	23/02/14	23/02/16	6,398 sh6 trades	$298.70avg.	$1,911,107.89	−11.8%
Vertex PharmaceuticalsVRTX	Open-market sale	23/02/13	23/02/14	4,798 sh4 trades	$298.90avg.	$1,434,126.48	−8.1%
Vertex PharmaceuticalsVRTX	Open-market sale	23/02/06	23/02/08	1,304 sh6 trades	$306.00avg.	$399,021.78	−1.9%